Suppr超能文献

基于Lyt抗原标志物和功能对肿瘤移植小鼠T淋巴细胞亚群的分析。

An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

作者信息

Lala P K, McKenzie I F

出版信息

Immunology. 1982 Dec;47(4):663-77.

Abstract

Small lymphocyte subsets were characterized radioautographically on the basis of several surface markers, . surface Ig (S-Ig), Thy-1 and Lyt (Ly-1, Ly-2 and 3) antigens in host lymphoid organs (thymus, spleen and blood) as well as at the tumour site at various stages of subcutaneous growth of two different syngeneic tumours—MPC-11 plasmacytoma and WEHI-164 fibrosarcoma in BALB/c mice. In both tumour-host combinations there was a rise in the levels of null (S-Ig, Thy-1) small lymphocytes as well as the Ly-23 subset of T small lymphocytes at all the sites examined. The absolute number of these two subsets also increased excepting the case of null cell rise in the thymus which was relative. The functional potentials of Lyt subsets were explored by employing and assays. While no appreciable levels of anti-tumour cytotoxic T cells (T) were detectable by a Cr release assay in the host spleen or the tumour-draining lymph nodes at any stage of growth of MPC-11 tumour, such T was generated by a co-cultivation of unprimed spleen cells with irradiated MPC-11 cells. These T were Thy-1 and Ly-12, as noted from antibody+C′ mediated abrogation of cytotoxicity. These results suggested that the generation of anti-tumour T was suppressed in tumour-bearing hosts. The possibility of a cell-mediated suppression was tested by an adoptive transfer of thymocytes or splenocytes from tumour-bearing mice into naive or pre-immunized recipients which then received fresh tumour transplants. This procedure caused a enhancement of tumour growth in three tumour-host combinations: MPC-11 or WEHI-164 tumour in BALB/c mice and W-1 fibrosarcoma in CBA mice. The suppressor lineage lymphocytes appearing were found to be Thy-1 and Ly-1, 2, as noted from antibody +C′ mediated abrogation of their tumour-growth promoting ability. They appeared earlier (7 days) in the thymus and later (>2 weeks) in the spleen and then persisted during the tumour lifetime. The parallel kinetics of the increase in the overall level of Ly-23 cells and the appearance of Ly-2(3) suppressor lineage T cells in tumour-bearing hosts may indicate that studies of T-cell surface markers may be useful in predicting changes in the functional lymphocyte subsets.

摘要

根据几种表面标志物,通过放射自显影法对宿主淋巴器官(胸腺、脾脏和血液)以及两种不同同基因肿瘤(BALB/c小鼠中的MPC-11浆细胞瘤和WEHI-164纤维肉瘤)皮下生长不同阶段肿瘤部位的小淋巴细胞亚群进行了表征。在两种肿瘤-宿主组合中,在所检查的所有部位,无标记(表面免疫球蛋白、Thy-1)小淋巴细胞以及T小淋巴细胞的Ly-23亚群水平均有所升高。除胸腺中无标记细胞的升高是相对的情况外,这两个亚群的绝对数量也增加了。通过采用铬释放试验和乳酸脱氢酶释放试验探究了Lyt亚群的功能潜能。在MPC-11肿瘤生长的任何阶段,通过铬释放试验在宿主脾脏或肿瘤引流淋巴结中均未检测到明显水平的抗肿瘤细胞毒性T细胞,但通过未致敏的脾细胞与经照射的MPC-11细胞共培养可产生此类T细胞。如通过抗体+C′介导的细胞毒性消除所观察到的,这些T细胞为Thy-1和Ly-(1,2)。这些结果表明,荷瘤宿主中抗肿瘤T细胞的产生受到抑制。通过将荷瘤小鼠的胸腺细胞或脾细胞过继转移到未致敏或预先免疫的受体中,然后给予新鲜肿瘤移植,测试了细胞介导抑制的可能性。此程序在三种肿瘤-宿主组合中导致肿瘤生长增强:BALB/c小鼠中的MPC-11或WEHI-164肿瘤以及CBA小鼠中的W-1纤维肉瘤。如通过抗体+C′介导的肿瘤生长促进能力消除所观察到的,出现的抑制谱系淋巴细胞为Thy-1和Ly-(1,2)。它们在胸腺中出现较早(7天),在脾脏中出现较晚(>2周),然后在肿瘤生存期持续存在。荷瘤宿主中Ly-23细胞总体水平的升高与Ly-(2,3)抑制谱系T细胞出现的平行动力学可能表明,T细胞表面标志物的研究可能有助于预测功能性淋巴细胞亚群的变化。

相似文献

9
Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.
Transplantation. 1974 Sep;18(3):244-50. doi: 10.1097/00007890-197409000-00007.

本文引用的文献

1
Cytokinetic analysis of tumor growth.肿瘤生长的细胞动力学分析
Proc Natl Acad Sci U S A. 1966 Dec;56(6):1735-42. doi: 10.1073/pnas.56.6.1735.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验